Veranova, a provider of process development and manufacturing of APIs, appointed Mike Riley Chief Executive Officer. Riley will assume responsibility for Veranova’s global business, effective Monday, May 8, and will report directly to the Veranova Board of Directors.

Riley is a seasoned executive, with over 25 years of professional experience, of which nearly 19 years have been spent in the pharmaceutical contract development and manufacturing operations (CDMO) industry building, leading, and growing global businesses. Most recently, Riley served at Catalent, Inc., as president of the biotherapeutics business, a multi-site business unit with 6,500 employees and revenue over $1 billion.



In a statement, the company said that Riley’s extensive knowledge of the life-sciences and CDMO industry, experience delivering innovative solutions to the pharmaceutical industry, and his proven track record of growing businesses make him ideally suited to lead Veranova as it prepares for its next phase of growth.